Skip navigation

News and Events

Keep up to date on AgNovos events and related news

AgNovos Healthcare receives ethics committee approvals for the RESTORE study in Netherlands and Austria

The study titled Randomized Controlled Study of a Local Osteo-Enhancement Procedure (LOEP) to Prevent Secondary Hip Fractures in Osteoporotic Women Undergoing Treatment of Index Hip Fractures (RESTORE) is a randomized, controlled, prospective, single blinded, multi-national study. The study is designed the impact that AGN1 LOEP has on the incidence of secondary hip fractures in subjects presenting with a first hip fracture.

Submissions in other sites are also underway.

The Company’s first product, the OSSURE LOEP (Local Osteo-enhancement Procedure) kit is CE-marked to treat local bone loss. The kit contains all of the instruments and ingredients necessary to prepare the proprietary, calcium-based, osteoconductive and tri-phasic implant material for injection into osteoporotic femurs using a minimally-invasive technique.